KIAA1217 in Human Disease: Emerging Evidence from Fusion Biology, Molecular Mechanisms, and Translational Perspectives
KIAA1217, also known as SKT or ETL4, was originally identified as a large, poorly characterized protein-coding gene and is increasingly implicated in human disease. Evidence is most developed in cancer, where KIAA1217 participates in fusions involving RET, FGFR2, and ALK. KIAA1217::RET has direct functional support in lung adenocarcinoma, activating ERK and PI3K/AKT signaling, whereas other fusions are supported mainly by sequencing and case-based observations. Independently, one experimental study indicated that KIAA1217 promotes hepatocellular carcinoma metastasis through JAK1/2-STAT3 signaling and epithelial–mesenchymal transition. Studies also implicate KIAA1217 in alternative splicing and multi-omics alterations, although these remain less mechanistically resolved. Beyond cancer, human genetic studies associate KIAA1217 with lumbar disc herniation and vertebral malformations. Experimental evidence for intervertebral disc development and synaptic organization derives primarily from murine Skt models and does not by itself establish equivalent functions of human KIAA1217. Other human and cross-species associations remain exploratory. This review integrates these findings using a multidimensional evidence framework and highlights unresolved links between KIAA1217 structural complexity and tissue-specific functions. Defining its interactome, disease-relevant isoforms, fusion-specific functions, and functional variants will be necessary to clarify KIAA1217-specific mechanisms and determine whether any of these findings have reproducible translational relevance.
Authors
- Linsha Dong
- Na Li (ORCID: https://orcid.org/0000-0002-4112-0944)
- Haixia Zhu
- Yanhong Wang
- Chenfei Qu
Institutions
- Qingdao Binhai University (CN)
Publication Details
- Journal
- Cells
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3390/cells15222054
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00